Indication
Retinoschisis
3 clinical trials
3 products
Product
RS1 AAV VectorClinical trial
A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked RetinoschisisStatus: Active (not recruiting), Estimated PCD: 2025-07-31
Product
IVB102Clinical trial
An Open-label, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IVB102 Injection in Subjects With X-linked Retinoschisis (XLRS)Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Prospective Clinical Trial to Evaluate the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in Retinoschisis: The AXIS TrialStatus: Recruiting, Estimated PCD: 2025-01-20
Product
Acetazolamide